Anzeige
Meldung des Tages: Gold im Fokus: Warum diese milliardenschwere Goldaktie vom aktuellen Goldumfeld profitieren könnte

Endo, Inc. News

Aktie
WKN:  ISIN:  US29290D1173 US-Symbol:  NDOI
Keine aktuellen Kursdaten verfügbar
Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Marktkapitalisierung *
-
Streubesitz
-
KGV
-
Index-Zuordnung
-

Endo, Inc. News

24.03.25 - PR Newswire
Endo Presents Dupuytren Contracture Data at the IFSSH and IFSHT Triennial Congress
Endo Presents Dupuytren Contracture Data at the IFSSH and IFSHT Triennial Congress PR Newswire
17.03.25 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RDUS, NDOI, TSVT, RDFN on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RDUS, NDOI, TSVT, RDFN on Behalf of Shareholders PR Newswire
13.03.25 - PR Newswire
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Endo, Inc.
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Endo, Inc. PR Newswire
13.03.25 - PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Endo, Inc. - NDOI
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Endo, Inc. - NDOI PR Newswire
13.03.25 - PR Newswire
Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader
Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader PR Newswire
13.03.25 - PR Newswire
Endo Reports Fourth-Quarter and Full-Year 2024 Financial Results
Endo Reports Fourth-​Quarter and Full-Year 2024 Financial Results PR Newswire
13.03.25 - PR Newswire
Endo Reports Fourth-Quarter and Full-Year 2024 Financial Results
Endo Reports Fourth-​Quarter and Full-Year 2024 Financial Results PR Newswire
12.03.25 - PR Newswire
Endo Announces Peyronie's Disease Presentation at the Annual Meeting of the Southeastern Section of the American Urological Association
Endo Announces Peyronie's Disease Presentation at the Annual Meeting of the Southeastern Section of the American Urological Association PR Newswire
11.03.25 - PR Newswire
Endo Announces Divestiture of International Pharmaceuticals Business
Endo Announces Divestiture of International Pharmaceuticals Business PR Newswire
11.03.25 - PR Newswire
Endo Announces Divestiture of International Pharmaceuticals Business
Endo Announces Divestiture of International Pharmaceuticals Business PR Newswire
10.03.25 - PR Newswire
Endo Reschedules Release of Fourth Quarter and Full Year 2024 Earnings Results and Conference Call
Endo Reschedules Release of Fourth Quarter and Full Year 2024 Earnings Results and Conference Call PR Newswire
10.03.25 - PR Newswire
Endo Reschedules Release of Fourth Quarter and Full Year 2024 Earnings Results and Conference Call
Endo Reschedules Release of Fourth Quarter and Full Year 2024 Earnings Results and Conference Call PR Newswire
27.02.25 - PR Newswire
Endo Presents Healthcare Provider Survey at Joint Meeting of International Society for the Study of Women's Sexual Health (ISSWSH) and International Society for Sexual Medicine (ISSM)
Endo Presents Healthcare Provider Survey at Joint Meeting of International Society for the Study of Women's Sexual Health (ISSWSH) and International Society for Sexual Medicine ...
27.02.25 - PR Newswire
Endo Presents Healthcare Provider Survey at Joint Meeting of International Society for the Study of Women's Sexual Health (ISSWSH) and International Society for Sexual Medicine (ISSM)
Endo Presents Healthcare Provider Survey at Joint Meeting of International Society for the Study of Women's Sexual Health (ISSWSH) and International Society for Sexual Medicine ...
21.02.25 - PR Newswire
Endo to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025
Endo to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025 PR Newswire
21.02.25 - PR Newswire
Endo to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025
Endo to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025 PR Newswire
17.02.25 - PR Newswire
Endo Launches "Steve's Journey," the First Branded Dupuytren's Contracture Commercial for XIAFLEX® (collagenase clostridium histolyticum)
Endo Launches "Steve's Journey," the First Branded Dupuytren's Contracture Commercial for XIAFLEX® (collagenase clostridium histolyticum) PR Newswire
17.02.25 - PR Newswire
Endo Launches "Steve's Journey," the First Branded Dupuytren's Contracture Commercial for XIAFLEX® (collagenase clostridium histolyticum)
Endo Launches "Steve's Journey," the First Branded Dupuytren's Contracture Commercial for XIAFLEX® (collagenase clostridium histolyticum) PR Newswire

Newssuche

Videos

newspaper
10:20 Uhr +8,33%
Technical Trading: Pfund Short im Februar
GBP/USD Short Typ: Turbo Open End WKN: VH3A2E Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »